AFT Pharmaceuticals Ltd
NZX:AFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
NZ |
|
Schindler Holding AG
F:SHR
|
CH |
|
Canada Rare Earth Corp
F:P4XA
|
CA |
|
Fortune Brands Innovations Inc
NYSE:FBIN
|
US |
|
B
|
Big Yellow Group PLC
OTC:BYLOF
|
UK |
|
C
|
Covista Inc
F:DVY
|
US |
|
Future Metals NL
F:3R10
|
AU |
|
Ragnar Metals Ltd
ASX:RAG
|
AU |
|
British Land Company PLC
LSE:BLND
|
UK |
|
B
|
Bank Polska Kasa Opieki SA
SWB:BP1
|
PL |
|
Lyft Inc
NASDAQ:LYFT
|
US |
|
Broadridge Financial Solutions Inc
NYSE:BR
|
US |
|
Mpact Ltd
OTC:MPPTF
|
ZA |
|
Decidr AI Industries Ltd
ASX:DAI
|
AU |
|
Certive Solutions Inc
OTC:CTVEF
|
CA |
|
W
|
West Japan Railway Co
F:WEJ
|
JP |
Bankruptcy Probability
AFT Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AFT Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NZ |
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
453m NZD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
639.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
344.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
279.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
130B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AFT Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AFT Pharmaceuticals Ltd has total debt of 41.6m NZD. This includes both short-term (0 NZD) and long-term (41.6m NZD) debt.
You can find a full breakdown on its Balance Sheet.